Company Quick10K Filing
Zivo Bioscience
10-K 2020-12-31 Filed 2021-02-25
S-1 2020-12-09 Public Filing
10-Q 2020-09-30 Filed 2020-11-12
10-Q 2020-06-30 Filed 2020-08-13
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-03-26
10-Q 2019-09-30 Filed 2019-10-28
10-Q 2019-06-30 Filed 2019-08-07
10-Q 2019-03-31 Filed 2019-05-13
10-K 2018-12-31 Filed 2019-02-12
10-Q 2018-09-30 Filed 2018-11-14
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-04-23
10-K 2017-12-31 Filed 2018-02-21
10-Q 2017-09-30 Filed 2017-10-19
10-Q 2017-06-30 Filed 2017-08-11
10-Q 2017-03-31 Filed 2017-05-12
10-K 2016-12-31 Filed 2017-03-31
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-12
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-03-29
10-Q 2015-09-30 Filed 2015-11-13
10-Q 2015-06-30 Filed 2015-08-13
10-Q 2015-03-31 Filed 2015-05-13
10-K 2014-12-31 Filed 2015-04-06
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-03-31
10-Q 2013-09-30 Filed 2013-11-12
10-Q 2013-06-30 Filed 2013-08-13
10-Q 2013-03-31 Filed 2013-05-06
10-K 2012-12-31 Filed 2013-03-25
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-15
10-Q 2011-09-30 Filed 2011-11-21
10-Q 2011-06-30 Filed 2011-08-22
10-Q 2011-03-31 Filed 2011-05-20
10-K 2010-12-31 Filed 2011-04-15
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-12
10-Q 2010-03-31 Filed 2010-05-17
10-K 2009-12-31 Filed 2010-04-14
8-K 2020-11-11
8-K 2020-11-11
8-K 2020-03-04
8-K 2020-03-03
8-K 2019-11-29
8-K 2019-05-01
8-K 2019-05-01
8-K 2019-04-08
8-K 2018-12-31
8-K 2018-11-12
8-K 2018-11-07
8-K 2018-11-07
8-K 2018-05-29
8-K 2018-05-17
8-K 2018-01-31
8-K 2018-01-10

Zivo Bioscience Financials

ZIVO Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI) 0% 1,546,418 322,654 0 0 0 0 -853,740
1 800 Flowers Com (FLWS) 944,324 42% 13.3 6% 664,955 335,559 1,266,390 533,727 36,761 75,090 1,000,932
10x Genomics (TXG) 4,804,979 75% -490.3 -2% 572,815 151,367 61,207 45,727 -9,603 -8,887 4,357,180
12 Retech (RETC) 0 32% -0.1 -1,385% 1,118 20,421 625 199 -15,491 -14,800 966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH) 33,711 0% 0.4 -5% 164,088 108,405 18,194 0 -7,969 -8,017 -2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH) 25% -2.4 -15% 18,527 23,194 27,219 6,699 -2,862 -1,433 3,396
1895 Bancorp of Wisconsin (BCOW) 46,152,715 12,508.1 -0% 441,187 382,722 0 0 -44 3,689 46,142,359
1st Constitution Bancorp (FCCY) 164,504 0% 4.4 1% 1,342,565 1,204,038 490 0 13,787 32,503 143,748
1st Franklin Financial (FFC) 3,551 -0.6 7% 905,107 644,730 0 0 62,078 80,004 -45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE) 1,200,033 7.9 1% 6,691,070 5,858,028 0 0 70,061 136,342 1,072,548
2050 Motors (ETFM) 0 -0.2 -166,272,400% 0 1,849 0 0 -1,663 -1,654 250
21Vianet Group (VNET) 6,005,116 0% 11,150,717 5,787,533 0 0 0 0 3,344,095
22nd Century (XXII) 301,854 1% -14.1 -36% 61,864 6,554 25,706 304 -22,433 -21,464 301,826
1Life Healthcare (ONEM)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash6022613247262552814939731102111162017259265855071,008241,2253179867822838944415
Accounts Receivable
Inventory160
PP&E12584663160010094888175691001001001001001001001001001001001001001000100000
Assets3664634172342214962,0112,1741,7841,5411,59310218311910273350917507371,2392061,4294,2102,78774027941210411270
Accounts Payable6096616559399158039394836006824831,2261,3821,1871,2191,3261,2501,1118246667697606355421,1324503934228031,166962
Long-Term Debt1,22510,063
Liabilities1,6632,4952,8724,1905,0989,10712,54811,7686,6676,5489,6366,4717,5408,0748,7759,57010,46511,20613,51914,35916,57416,77619,46720,51522,34619,57821,85022,69424,80311,27110,973
Stockholders' Equity-1,297-2,031-2,454-3,956-4,877-8,610-10,537-9,594-4,883-5,007-8,043-6,369-7,357-7,954-8,673-9,497-10,116-11,115-12,769-13,621-15,335-16,571-18,038-16,304-19,559-18,838-21,572-22,282-24,700-11,159-10,903
Income Statement ($'000)2011-09-302011-12-312012-03-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue364000000000000000000000000
Cost of Revenue
Gross Profit
R&D671321231293112713073914065096662093462202583131631261883094965511,026927774555366948526
SG&A153272153264472339114271262325492541912253542012041952322062222461,453332307317309370340
Tax-0000000000000000000000000
Net Income-542-1,409-1,059-927-4,749-4,6812613,962-668-3,340726-1,287-2,010-1,475-1,018-1,393-2,294-1,140-1,232-1,862-1,427-2,869-3,880-3,846-3,573-4,119-3,057-2,540-1,781
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-524-534-556-852-783-795-681-543-1,215-298-402-853-556-487-758-525-440-820-529-1,123-1,228-1,362-874-1,778-1,230-576-1,154-1,326
Cash Investing0000-33100000000000000000000
Cash Financing6894415351,0811,1411,0062844771,2861984118575604831,0012921,0007421,0301402,4284556552,3587801921,1931,298